Our identification of Moesin as a hub gene in human and mouse tauopathy networks aligns with the findings of the consortia, and our studies in Drosophila provide the mechanistic insight into the consequences of Moesin activation in tauopathy that are critical for drug development. This evidence concerns the gene MSN and tauopathy.